Skip to main content

Table 3 Possible causes of non-adherence to the guidelines evaluated and transferral for analysis

From: Patient and physician related factors of adherence to evidence based guidelines in diabetes mellitus type 2, cardiovascular disease and prevention: a cross sectional study

Patient answer

Transferred to

Physician answer

Transferred to

I do not know

I do not know

I do not know

Falsely not indicated GP

I do not need it

I do not need it

Not indicated

 

I do not want it

I do not want it

Noncompliance

Noncompliance

  

Avoidance of polypharmacy

Avoidance of polypharmacy

  

Specialist did not prescribe it

Falsely not indicated s/h*

I do not take it any more

Adverse drug event

Contraindication

Contraindication

 

Falsely discontinued

Patient does not take it anymore

Adverse drug event

   

Falsely discontinued

 

(or one of the above)

 

(or one of the above)

Other

Allocation to one of the above

Other

Allocation to one of the above

  1. * Falsely not indicated specialist / hospital (when a certain therapy was not initiated or recommended by specialists or physicians in the hospital, and the GP adhered to this recommendation even though in fact there was an indication for the drug).
  2. Defined as a stop of treatment triggered by the physician despite guidelines recommending a continuation of the therapy (e.g. discontinuation of statin therapy after reaching target values for LDL-cholesterol which then rose above target again).